ACCESSION: MSBNK-SMB_Measured-HSA001P0169022
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'BLK02_17426': {'bp': 3571553.0, 'sum': 4614000.0}, '4_posi_17401': {'bp': 2816781.0, 'sum': 3685591.0}, 'ProcedureBlank_17405': {'bp': 2892477.0, 'sum': 3745860.0}, '14_posi_17405': {'bp': 2521143.0, 'sum': 3314119.0}, '17_posi_17381': {'bp': 2523821.0, 'sum': 3311294.0}, '16_posi_17424': {'bp': 2653314.0, 'sum': 3612717.0}, '2_posi_17408': {'bp': 3064738.0, 'sum': 4028836.0}, '8_posi_17428': {'bp': 2563570.0, 'sum': 3444866.0}, '10_posi_17381': {'bp': 2778756.0, 'sum': 3661914.0}, '3_posi_17425': {'bp': 3033675.0, 'sum': 3954982.0}, '6_posi_17400': {'bp': 2716265.0, 'sum': 3514953.0}, '13_posi_17422': {'bp': 2822702.0, 'sum': 3771889.0}, '7_posi_17406': {'bp': 2679960.0, 'sum': 3464231.0}}
COMMENT: RETENTION_TIME_STDEV 0.032
COMMENT: PRECURSOR_M/Z_RAW 169.144415
COMMENT: PRECURSOR_M/Z_STDEV 0.000057
COMMENT: PRECURSOR_IN_MS1 mz 169.144743; int 468.059; delta(ppm) 1.264267
COMMENT: PROPOSED_CHARGE_STATE +1; mz 170.148052; int 39.093; cor 0.747
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+2ACN+H; mz 251.197912; int 15.293; cor 0.618
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 128.118206; int 761.388; cor 0.698
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 128.118206; int 761.388; cor 0.698
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+NH4; mz 104.118201; int 12.535; cor 0.725
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 128.118206; int 761.388; cor 0.698
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.172; C8H16N4; [M+H]+; delta(ppm) -0.172478
COMMENT: PROPOSED_MF SevenGoldenRules 0.205; C6H13N3; [M+ACN+H]+; delta(ppm) -0.204546
COMMENT: PROPOSED_MF SevenGoldenRules 0.279; C4H10N2; [M+2ACN+H]+; delta(ppm) -0.278796
COMMENT: PROPOSED_MF MS-FINDER 3.032; C4H10N2; [M+2ACN+H]+; delta(ppm) 495602.102087
COMMENT: PROPOSED_MF MS-FINDER 2.965; C6H13N3; [M+ACN+H]+; delta(ppm) 97478.066502
COMMENT: PROPOSED_MF MS-FINDER 2.939; C8H16N4; [M+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.924; C4H10N2; [M+C4H6N2+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.924; C6H13N3; [M+C2H3N+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.924; C8H16N4; [M+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H10N2; [M+C4H6N2+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H13N3; [M+C2H3N+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H16N4; [M+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.646; C4H10N2; [M+C4H6N2+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.646; C8H16N4; [M+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.646; C6H13N3; [M+C2H3N+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.148; C10H18NO; [M+H]+; delta(ppm) -8.109175
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.148; C8H15O; [M+C2H3N+H]+; delta(ppm) -8.109175
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H10N2; [M+C4H6N2+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H16N4; [M+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H13N3; [M+C2H3N+H]+; delta(ppm) -0.171285
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.811; ZBFHXDNNFOOFLY-UHFFFAOYNA-N; [M+H]+; C1CN2CN1CN1CCN(C1)C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.476; JCEZJHOHMHDSJO-UHFFFAOYNA-N; [M+H]+; NC(CCCNC(N)=N)C=C=C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.284; XTWBQKHPKUSVPL-UHFFFAOYSA-N; [M+H]+; N#CNC(=NC(C)C)NC(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.275; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+2ACN+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+2ACN+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+2ACN+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.087; UVMLHMAIUVSYOL-UHFFFAOYSA-N; [M+ACN+H]+; Galegine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.084; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+2ACN+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.057; JCEZJHOHMHDSJO-UHFFFAOYNA-N; [M+H]+; &alpha; -allenylagmatine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.057; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+2ACN+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.976; PIQOJRYKDAUYSO-MDOHGIEYNA-N; [M+ACN+H]+; UNPD124876
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.945; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+2ACN+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.945; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.783; XTWBQKHPKUSVPL-UHFFFAOYSA-N; [M+H]+; N'-cyano-N,N''-bis(propan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.766; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+2ACN+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.670; ISCMYZGMRHODRP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(iminomethylideneamino)-N,N-dimethylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.658; ZBFHXDNNFOOFLY-UHFFFAOYNA-N; [M+H]+; 1,3,6,8-tetraazatricyclo(6.2.1.1(3,6))dodecane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JCEZJHOHMHDSJO-UHFFFAOYNA-N; [M+H]+; &alpha; -allenylagmatine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ISCMYZGMRHODRP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(iminomethylideneamino)-N,N-dimethylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+2ACN+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.980; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+2ACN+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.713; XTWBQKHPKUSVPL-UHFFFAOYSA-N; [M+H]+; N'-cyano-N,N''-bis(propan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.698; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+2ACN+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.693; ZBFHXDNNFOOFLY-UHFFFAOYNA-N; [M+H]+; 1,3,6,8-tetraazatricyclo(6.2.1.1(3,6))dodecane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.677; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+2ACN+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.433; PIQOJRYKDAUYSO-MDOHGIEYNA-N; [M+ACN+H]+; UNPD124876
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.415; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+2ACN+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.415; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+2ACN+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.415; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.379; UVMLHMAIUVSYOL-UHFFFAOYSA-N; [M+ACN+H]+; Galegine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.371; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+2ACN+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.535; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.157; YHNNUDUEGSHVGJ-UHFFFAOYSA-N; [M+H]+; 1,3,6,8-tetrazatricyclo[4.4.1.13,8]dodecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.691; QUUYRYYUKNNNNS-UHFFFAOYSA-N; [M+ACN+H]+; piperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.595; UVMLHMAIUVSYOL-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methylbut-2-enyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.333; RSFHAOJRAMLILZ-UHFFFAOYSA-N; [M+H]+; 2-[2-(dimethylamino)ethyl]-5-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.107; CEQUIOLAKNWNOW-UHFFFAOYSA-N; [M+ACN+H]+; piperidine-4-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.031; VUABPLGJPNFBHR-UHFFFAOYSA-N; [M+ACN+H]+; piperidine-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.003; WOCSROBZETXEHI-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4,5-dihydro-1H-imidazol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.709; RTZLTXRMHPWODA-BCVWCTNASA-N; [M+ACN+H]+; (2R,4R)-2,4,6-trimethyl-1,3,5-triazabicyclo[3.1.0]hexane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.469; KFQRCGONYHVDKX-UHFFFAOYSA-N; [M+ACN+H]+; 1-azidohexane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.419; ZHVKHIASMJZTAH-UHFFFAOYSA-N; [M+ACN+H]+; 3-[amino(propan-2-yl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.376; FUZDFUUBQLKDPP-UHFFFAOYSA-N; [M+ACN+H]+; 2-pyrrolidin-1-ylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.335; BGBBOYOXJQCQHL-UHFFFAOYSA-N; [M+H]+; 1-(3-butan-2-yl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.193; BILRFUQRWMIDOF-UHFFFAOYSA-N; [M+ACN+H]+; 5,5-dimethyl-4,6-dihydro-1H-pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; ZBFHXDNNFOOFLY-UHFFFAOYSA-N; [M+H]+; 1,3,6,8-tetrazatricyclo[6.2.1.13,6]dodecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.174; BTJYVJFADSUPSG-UHFFFAOYSA-N; [M+H]+; N,N-dipropyl-1,2,4-triazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; DMYTZCNVNCOMHO-YRNVUSSQSA-N; [M+H]+; 2-[(E)-(2-methylcyclohexylidene)amino]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.154; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+2ACN+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; FDWQPDLACZBQBC-PLNGDYQASA-N; [M+2ACN+H]+; N-[(Z)-ethylideneamino]-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; JCEZJHOHMHDSJO-UHFFFAOYSA-N; [M+H]+; NA
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.018; OYQZMQLGNFRLLJ-UHFFFAOYSA-N; [M+H]+; 5-heptan-4-yl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; INTMMHZKGCDQGT-UHFFFAOYSA-N; [M+2ACN+H]+; diethyldiazene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.974; BIWZYRJXBPPLLA-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; PYBBRDLRXFWWFU-UHFFFAOYSA-N; [M+2ACN+H]+; 3-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; PAXRVGDTBDATMF-UHFFFAOYSA-N; [M+2ACN+H]+; N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; FPYGTMVTDDBHRP-OWOJBTEDSA-N; [M+2ACN+H]+; (E)-but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; MRYNEEIGLSDRKH-UHFFFAOYSA-N; [M+2ACN+H]+; azetidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; UYLSVYARXBFEKV-UHFFFAOYSA-N; [M+2ACN+H]+; cyclobutane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; VMAXJDJIFGIBGH-UHFFFAOYSA-N; [M+2ACN+H]+; azetidin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; VHCQWQAYVBRQQC-ZXZARUISSA-N; [M+2ACN+H]+; (1R,2S)-cyclobutane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.815; HTFFABIIOAKIBH-UHFFFAOYSA-N; [M+2ACN+H]+; diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; IDXUYTGVGZLSFF-UHFFFAOYSA-N; [M+H]+; N,N-diethyl-2-(1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.738; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+2ACN+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; NQPTWMKTGPWPMX-UHFFFAOYSA-N; [M+2ACN+H]+; N-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.703; FYPXPUVQGHCUMR-UHFFFAOYSA-N; [M+H]+; 2-(1-propan-2-yltriazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.598; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+2ACN+H]+; butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.542; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; JYQKJYDDOGBPOA-UHFFFAOYSA-N; [M+2ACN+H]+; 1-cyclopropyl-1-methylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.496; WKWPTGYQIHKPSJ-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylprop-2-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.452; HQFQTTNMBUPQAY-UHFFFAOYSA-N; [M+2ACN+H]+; cyclobutylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.413; FBFGFCAGFFHMPG-UHFFFAOYSA-N; [M+2ACN+H]+; cyclopropylmethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.410; HBRZQKXSEKTPEW-UHFFFAOYSA-N; [M+2ACN+H]+; but-3-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.359; JATTWGKYNBEIMH-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(aminomethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.357; PRCGMIFKQRXNBS-UHFFFAOYSA-N; [M+2ACN+H]+; 2-methylidenepropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.222; JMHYNOCZNRXMLN-UHFFFAOYSA-N; [M+2ACN+H]+; N,N'-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.220; SVKQJKDFMLYPSM-UHFFFAOYSA-N; [M+2ACN+H]+; N'-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.215; MLTKZVHOZAKJMV-UHFFFAOYSA-N; [M+2ACN+H]+; 3-ethyl-3-methyldiaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.212; SPPFMFXKGYNRER-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methylpyrazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -16.974; GLUUGHFHXGJENI; [M+C4H6N2+H]+; Pipersol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -43.967; MRYNEEIGLSDRKH; [M+C4H6N2+H]+; 2-Aminomethylazetidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -51.848; FPYGTMVTDDBHRP; [M+C4H6N2+H]+; E-Bed diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.414; NGXSWUFDCSEIOO; [M+C4H6N2+H]+; 3-Pyrrolidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -109.714; JUDVCTHUDHRSSD; [M+C4H6N2+H]+; 2-methylimidazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.641; INTMMHZKGCDQGT; [M+C4H6N2+H]+; Azoaethan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.877; SBMSLRMNBSMKQC; [M+C4H6N2+H]+; aminopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.129; YHNNUDUEGSHVGJ; [M+H]+; Dezant
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.379; ZBFHXDNNFOOFLY; [M+H]+; Epitope ID:167838
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.747; RXKUYBRRTKRGME; [M+C4H6N2+H]+; Butyramidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.148; ZHVKHIASMJZTAH; [M+C2H3N+H]+; 3-(1-Isopropylhydrazino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.762; YYIDBCAXHPPALW; [M+C2H3N+H]+; Bis(dimethylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.332; FDWQPDLACZBQBC; [M+C4H6N2+H]+; Acetaldehyde dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.885; KFQRCGONYHVDKX; [M+C2H3N+H]+; Hexylazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.411; QUUYRYYUKNNNNS; [M+C2H3N+H]+; 1-(aminoiminomethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.679; RTZLTXRMHPWODA; [M+C2H3N+H]+; 2,4,6-trimethyl-1,3,5-triazabicyclo[3.1.0]hexane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.631; UVMLHMAIUVSYOL; [M+C2H3N+H]+; Galegine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.961; IDXUYTGVGZLSFF; [M+H]+; 1-(2-Diethylaminoethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.286; OYQZMQLGNFRLLJ; [M+H]+; 5-heptan-4-yl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.189; PIQOJRYKDAUYSO; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.689; BTJYVJFADSUPSG; [M+H]+; N,N-dipropyl-1,2,4-triazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.631; RSFHAOJRAMLILZ; [M+H]+; 2-(2-dimethylaminoethyl)-5-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.623; XTWBQKHPKUSVPL; [M+H]+; 1-cyano-2,3-di(propan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.146; JCEZJHOHMHDSJO; [M+H]+; alpha -allenylagmatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.479; GLUUGHFHXGJENI; [M+C4H6N2+H]+; Pipersol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.103; YHNNUDUEGSHVGJ; [M+H]+; Dezant
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.043; ZHVKHIASMJZTAH; [M+C2H3N+H]+; 3-(1-Isopropylhydrazino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -35.986; GLUUGHFHXGJENI; [M+C4H6N2+H]+; piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -45.154; XMUIKZODBRYDCK; [M+C2H3N+H]+; 2,3,4,5,6,9-hexahydro-1H-1,4,7-triazonine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -45.791; BCOKXHFZZWDXPM; [M+C2H3N+H]+; 2,3,4,5,6,7-hexahydro-1H-1,4,7-triazonine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -46.145; FPYGTMVTDDBHRP; [M+C4H6N2+H]+; 4-Azaniumylbut-2-enylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -53.007; DZCFEGFIXJLAHW; [M+C2H3N+H]+; 1-Piperazineethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -53.981; JBHGYPPQIWRSIJ; [M+C2H3N+H]+; N-(piperazin-1-ylmethyl)methanimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -54.940; JVZZMVRWQYFFTR; [M+H]+; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.298; FLZFSFNCQQYPHA; [M+C2H3N+H]+; 1-Piperazinoethaneimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -56.447; VLFOONLJLTYLPI; [M+C2H3N+H]+; N-methyl-1-piperazin-1-ylmethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -56.996; NGXSWUFDCSEIOO; [M+C4H6N2+H]+; (S)-3-Aminopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.193; WWVMUDITFSYKRH; [M+C2H3N+H]+; N'-[(Z)-2-aminoethenyl]-N'-ethenylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.835; YBNIRIKSPYFNNV; [M+C2H3N+H]+; 2-Piperazin-2-ylideneethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.705; VQNHHJBAPPTPEO; [M+C2H3N+H]+; N-piperazin-1-ylethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.971; FPPZNDSHVXVTSG; [M+C2H3N+H]+; 2-Methyl-1,4,5,6,7,8-hexahydro-1,3,6-triazocine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.864; FWVPZJRCVXJIRQ; [M+H]+; 1,4,7,10-Tetrazacyclododeca-6,10-diene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.981; XJASIIXXMQZIDJ; [M+H]+; 1,4,7,10-Tetrazacyclododeca-7,10-diene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.385; KKGJQGHGLGXNII; [M+C4H6N2+H]+; Dehydroputrescine (ambiguous)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -69.858; AAISMJAEJQLCMW; [M+H]+; 1,4,7,10-Tetrazacyclododeca-4,10-diene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -71.061; DKYBVKMIZODYKL; [M+C4H6N2+H]+; Hexahydropyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.086; WKWPTGYQIHKPSJ; [M+C4H6N2+H]+; (2-Methylprop-2-en-1-yl)hydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.321; MRYNEEIGLSDRKH; [M+C4H6N2+H]+; [(2R)-azetidin-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.156; XDUGYGAAFBEXCE; [M+H]+; 2-(1,4,7-Triazonan-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.691; TZCNQEVGXCFQDP; [M+H]+; 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.222; KKCFZIWVUXRCME; [M+H]+; 5-Piperazin-1-yl-1,2,3,6-tetrahydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -85.683; ACPWGAXCVWNYSW; [M+C4H6N2+H]+; But-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.697; GFFBWNCEKDHCJO; [M+H]+; 1,4,7,10-Tetrazacyclododeca-7,9-diene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.554; LTEQHXNIPJCWSH; [M+H]+; 2-(2-Piperazin-1-ylethylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -92.665; RXKUYBRRTKRGME; [M+C4H6N2+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.819; SBMSLRMNBSMKQC; [M+C4H6N2+H]+; Pyrrolidin-1-ylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.328; VGKMBOVAHCLXMH; [M+H]+; 1,4,7,10-Tetrazatricyclo[5.5.0.04,10]dodecane
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.522; JVZZMVRWQYFFTR; [M+H]+; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.413; GLUUGHFHXGJENI; [M+C4H6N2+H]+; piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.120; XMUIKZODBRYDCK; [M+C2H3N+H]+; 2,3,4,5,6,9-hexahydro-1H-1,4,7-triazonine
COMMENT: CONFIDENCE Level 5: Exact mass of interest 169.144744; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 34.945
MS$FOCUSED_ION: PRECURSOR_M/Z 169.144744
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-0900000000-59573564538eae036af7
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  69.0446682 3.9506 ? 69.045294 1.1297 0.67 0.2637 13
  70.0649615 1.9957 ? 70.065581 1.4415 0.44 0.1030 10
  71.0603745 16.3496 ? 71.060988 0.4362 1.76 0.4066 13
  72.0442612 5.0718 ? 72.044868 1.2354 0.85 -0.1264 13
  83.0602840 3.8529 ? 83.060788 1.2401 0.78 0.0879 13
  85.0760339 7.2813 ? 85.076513 1.5398 0.84 0.6374 13
  87.0916246 3.3282 ? 87.092078 1.5731 0.90 0.0769 13
  97.0759342 5.2271 ? 97.076279 1.1331 0.92 0.4560 13
  98.0711981 2.2582 ? 98.071535 1.9170 0.51 0.1374 13
  99.0552183 4.5920 ? 99.055548 0.7773 0.81 0.3791 13
  99.0916686 11.2620 ? 99.091998 0.8881 1.28 0.7143 13
  101.0708258 4.5744 ? 101.071139 1.4544 0.67 0.1374 13
  109.0395627 2.0404 ? 109.039800 2.1277 0.60 -0.1152 10
  109.0760022 2.4796 ? 109.076239 1.5494 0.29 0.6182 11
  124.0869618 19.2229 ? 124.087017 0.4594 1.87 0.4615 13
  125.0708940 5.8861 ? 125.070935 1.2633 0.99 0.6703 13
  125.0948597 40.0926 ? 125.094901 0.4237 2.57 0.8132 13
  126.0662912 7.2786 ? 126.066318 1.8086 1.47 -0.3462 13
  126.1025932 59.3001 ? 126.102620 0.3569 4.31 0.9396 13
  140.1182912 3.4676 ? 140.118195 1.4131 1.33 0.2747 13
  141.1021879 4.1046 ? 141.102092 1.0276 0.97 -0.3077 13
  151.0977344 3.9805 ? 151.097632 1.5487 0.74 0.1044 13
  152.0818473 9.2152 ? 152.081744 1.0849 1.82 -0.0549 13
  152.1181535 14.6489 ? 152.118050 0.6311 1.34 0.7363 13
  169.0968852 32.3308 ? 169.096771 0.4672 1.91 0.7692 13
  169.1447576 999.0000 ? 169.144643 0.3252 0.00 1.0000 13
PK$NUM_PEAK: 26
PK$PEAK: m/z int. rel.int.
  69.044668 3.95 3
  70.064961 2.00 1
  71.060374 16.35 16
  72.044261 5.07 5
  83.060284 3.85 3
  85.076034 7.28 7
  87.091625 3.33 3
  97.075934 5.23 5
  98.071198 2.26 2
  99.055218 4.59 4
  99.091669 11.26 11
  101.070826 4.57 4
  109.039563 2.04 2
  109.076002 2.48 2
  124.086962 19.22 19
  125.070894 5.89 5
  125.094860 40.09 40
  126.066291 7.28 7
  126.102593 59.30 59
  140.118291 3.47 3
  141.102188 4.10 4
  151.097734 3.98 3
  152.081847 9.22 9
  152.118154 14.65 14
  169.096885 32.33 32
  169.144758 999.00 999
//
